Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Harvard Business School
Merck
Dow

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Claims for Patent: 8,951,513

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,951,513
Title:Methods and apparatus for enhanced recovery of cells and of cell-enriched matrix from tissue samples
Abstract: This document describes methods and an apparatus for recovery of a cell-enriched matrix and cells (e.g., regenerative cells) from a tissue sample. In some embodiments, at least two rounds of acceleration and deceleration are performed.
Inventor(s): Alt; Eckhard U. (Houston, TX), Coleman; Michael E. (Houston, TX), Stubbers; Ron (Houston, TX)
Assignee: Ingeneron Incorporated (Houston, TX)
Application Number:13/329,143
Patent Claims:1. A method for recovering regenerative cells from a body tissue, comprising placing the body tissue together with at least a proteolytic enzyme in an aqueous medium in at least one container, and agitating the body tissue and enzyme by subjecting the container to repeated rounds of rotational acceleration and deceleration about an axis in a centrifuge for a predetermined period of time sufficient for said recovery, including maintaining the container inverted at an angle to said axis of rotation of the container during said repeated rounds of acceleration and deceleration thereof, said angle enabling agitation of said tissue and enzyme under conflicting centrifugal and gravitational forces.

2. The method of claim 1, including maintaining the container in a temperature controlled environment in a range from 26.degree. C. to 42.degree. C. during the repeated rounds of acceleration and deceleration.

3. The method of claim 1, wherein the body tissue is adipose tissue, and the proteolytic enzyme is at least one of a collagenase and a neutral protease.

4. The method of any of claims 1-3, wherein the body tissue is adipose tissue comprising regenerative cells located primarily in the vascular and perivascular space with the regenerative cells attached to lamina elastica interna, and aiding the regenerative cell recovery from the body tissue by use of the proteolytic enzyme as a combination of collagenase and at least one neutral protease.

5. A method for dissociating regenerative cells from a body tissue, comprising confining the body tissue together with at least one proteolytic enzyme in an aqueous fluid in a container to a level less than its full capacity, maintaining the container affixed angularly to a rotor of a centrifuge with one end of the container elevated relative to the other end thereof nearest the axis of rotation of the rotor, and agitating the contents of the container by applying rotational force to the rotor in a repetitive sequence of at least one start-stop round per minute to repetitively accelerate and decelerate the container rotationally about said rotor axis.

6. The method of claim 5, including controllably maintaining the temperature of the centrifuge interior during the repetitive acceleration and deceleration rounds of the container.

7. The method of claim 5, including collecting the dissociated regenerative cells after steps of at least washing and centrifugation following said repetitive sequence.

8. The method of any of claims 5-7, wherein the body tissue is adipose tissue, the proteolytic enzyme comprises a combination of collagenase and at least one neutral protease, and maintaining the interior of the centrifuge at a temperature in a range from 26.degree. C. to 42.degree. C. during agitation of the contents of the container.

9. The method of claim 5, wherein said body tissue is lipoaspirate.

10. The method of claim 9, further including maintaining a temperature in the range of from 26.degree. C. to 42.degree. C. inside said centrifuge while agitating the contents of said container.

11. The method of claim 5, including applying said rotational force to the rotor sufficient to produce centrifugal force in a range from about 50 g to about 4000 g on the container at times during the repetitive acceleration and deceleration rounds.

12. The method of claim 9, wherein said proteolytic enzyme is at least one of a collagenase and a neutral protease.

13. A method for recovering regenerative cells from a body tissue, comprising placing the body tissue together with at least a proteolytic enzyme in an aqueous medium in at least one container, and agitating the body tissue and enzyme by subjecting the container to repeated rounds of rotational acceleration and deceleration about an axis in a centrifuge for a predetermined period of time sufficient for said recovery, wherein the body tissue and the enzyme at least partially fill said container; and further including subjecting the resulting contents of said container to said repeated rounds of acceleration and deceleration using said rotational force applied to a rotatable shaft on which said container is maintained in a position such that gravitational force is directed opposite that of centrifugal force on said contents.

14. The method of claim 13, including detachably maintaining said container on a rotor on said rotatable shaft in said position at an upward inclination between a horizontal plane and a substantially vertical orientation of the shaft for rotation thereon, such that one end of the container is closer to the rotatable shaft and the opposite end thereof is elevated relative to said one end, rotating said container about said axis of the shaft at a rate of more than one round per minute of acceleration and deceleration, whereby to facilitate mixing of said contents, while maintaining the temperature of the interior of said centrifuge in a range between 26.degree. C. and 42.degree. C.

15. The method of claim 13, including applying said rotational force to produce said centrifugal force within a range from about 50 g to about 3000 g.

16. The method of claim 13, wherein the body tissue is lipoaspirate.

17. The method of claim 13, including utilizing multiple units of the container, each container having a proximal end into which the body tissue and enzyme are placed, and coupling the multiple containers angularly spaced apart to said rotatable shaft of the centrifuge such that one of the proximal end and the distal end of each container is coupled closest to the axis of rotation of the rotatable shaft and lies below its other end for the repeated rounds of rotational acceleration and deceleration on the rotatable shaft.

18. A method for processing a body tissue to recover cells therefrom, comprising introducing into a container the body tissue together with at least one proteolytic enzyme, detachably coupling the container radially to a rotor configurable to retain the container at one of (i) a fixed angle or (ii) an angle that varies with rotational force on the container, rotating the container under rotational forces through sequential rounds of acceleration and deceleration at a rate of at least one round per minute, and recovering cells from the body tissue as a combined result of conflicting centrifugal and gravitational forces on the container.

19. A method for dissociating regenerative cells from a body tissue, comprising loading the body tissue together at least one enzyme in an aqueous fluid in a container, and transmitting centrifugal forces to the contents of the container by rotating the container about a centrifuge axle in repeated rounds of acceleration and deceleration without decoupling the container from the axle or otherwise disturbing said contents between said repeated rounds, whereby to promote dissociation of the regenerative cells from the body tissue, including coupling an end of the container radially from and at an acute angle to said centrifuge axle for moving the contents of the container under centrifugal forces in a direction opposite their direction of movement under gravitational force.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
AstraZeneca
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.